“Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy With Omalizumab in Patients With Chronic Idiopathic Spontaneous Urticaria (CIU CSU)”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S51, https://doi.org/10.25251/skin.2.supp.51.